Navigation Links
Patheon to Present New Updates in Drug Formulation and Bioavailability
Date:3/21/2013

(PRWEB) March 21, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that the company will present at a program titled “New Updates in Drug Formulation and Bioavailability” on April 9, 2013, organized jointly by Medicon Valley Alliance, KemiVärlden Biotech and Patheon.

A presentation “Solubility and Bioavailability Enhancement for Poorly Soluble Drugs” will be given by Anil Kane, Executive Director, Global Formulation Sciences, Patheon Inc. on Tuesday, April 9, 2013 at 1:35 p.m. Central European Time. For more information on upcoming events, visit http://www.patheon.com/Knowledge-Library/Events.aspx.

Patheon representatives will also be available to meet during the program, showcasing several of Patheon’s key service offerings, including SoluPath™ - an innovative and cost-effective service used to identify an optimal drug delivery system for compounds with poor bioavailability. In a recent case study, SoluPath™ improved bioavailability by four times in just three months. Learn more by visiting the company’s website at http://www.patheon.com/Services/UniqueSolutions/SoluPath.aspx.    

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10546692.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Patheon to Present at 2013 DCAT Week
2. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
3. Patheon to Present at Informex USA
4. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
5. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
6. Leading Photonics and Laser Researchers to Present Latest Work at SPIE Optics + Optoelectronics
7. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
8. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
9. De nouvelles données mettent en évidence le fardeau considérable que représente la nycturie
10. Palatin Technologies To Present At The 25th Annual ROTH Conference
11. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2016)... , ... May 18, 2016 , ... Ryan Benton was ... life expectancy in the late teens to early twenties. DMD is a relatively common ... at the age of 22, Benton’s condition was critical. He met with the founder ...
(Date:5/17/2016)... , ... May 17, 2016 , ... ... and BioSmartSA, a healthcare consultancy based in Saudi Arabia, have formed a partnership ... to healthcare providers in the Kingdom of Saudi Arabia (KSA). , The ...
(Date:5/17/2016)... 17, 2016 Strekin AG, ... Basel, Switzerland announced today the ... P38 mitogen-activated protein kinase.      (Logo: ... will build the necessary research foundation for the ... MAP Kinases play fundamental roles. Pamapimod has a ...
(Date:5/17/2016)... ... 17, 2016 , ... HOLLOWAY AMERICA, a stainless steel pressure vessel and tank ... on Thursday, May 19 in St. Louis, Missouri. The event will be held at ... a vendor showcase during the early afternoon of the event, where the company’s representatives ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):